Sex-Specific Genomic Biomarkers for Individualized Treatment of Life-Threatening Diseases

Table 4

Melanoma validation dataset distribution.

Melanoma validation set
Gender; (class)	Clinical endpoint; (abbrev., class)		Total; patients
	High survival and small tumor size; (HS/ST, “0”)	Low survival and nonsmall tumor size; (LS/NST, “1”)
Male (“0”)	1	7	8
Female (“1”)	1	8	9
Total	2	15	17